Literature DB >> 12391596

Amyloid-beta: a vascular sealant that protects against hemorrhage?

Craig S Atwood1, Glenda M Bishop, George Perry, Mark A Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12391596     DOI： 10.1002/jnr.10388

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN： 0360-4012            Impact factor:   4.164


× No keyword cloud information.
  10 in total

1.  A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.

Authors:  Rashid Deane; Itender Singh; Abhay P Sagare; Robert D Bell; Nathan T Ross; Barbra LaRue; Rachal Love; Sheldon Perry; Nicole Paquette; Richard J Deane; Meenakshisundaram Thiyagarajan; Troy Zarcone; Gunter Fritz; Alan E Friedman; Benjamin L Miller; Berislav V Zlokovic
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

Review 2.  Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.

Authors:  Meaghan C Creed; Norton W Milgram
Journal:  Age (Dordr)       Date:  2010-04-20

3.  Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease.

Authors:  Ai-Ling Lin; Wei Zheng; Jonathan J Halloran; Raquel R Burbank; Stacy A Hussong; Matthew J Hart; Martin Javors; Yen-Yu Ian Shih; Eric Muir; Rene Solano Fonseca; Randy Strong; Arlan G Richardson; James D Lechleiter; Peter T Fox; Veronica Galvan
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-26       Impact factor: 6.200

Review 4.  Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.

Authors:  Abhay P Sagare; Robert D Bell; Berislav V Zlokovic
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

Review 5.  Alzheimer disease.

Authors:  Rudy J Castellani; Raj K Rolston; Mark A Smith
Journal:  Dis Mon       Date:  2010-09       Impact factor: 3.800

Review 6.  The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease.

Authors:  Craig S Atwood; Richard L Bowen
Journal:  Horm Behav       Date:  2015-07-16       Impact factor: 3.587

Review 7.  Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics.

Authors:  Hyomin Jeong; Heewon Shin; Seungpyo Hong; YoungSoo Kim
Journal:  Exp Neurobiol       Date:  2022-04-30       Impact factor: 3.800

8.  PPARγ agonists regulate bidirectional transport of amyloid-β across the blood-brain barrier and hippocampus plasticity in db/db mice.

Authors:  Hao Wang; Fang Chen; Kai Long Zhong; Su Su Tang; Mei Hu; Yan Long; Ming Xing Miao; Jian Min Liao; Hong Bing Sun; Hao Hong
Journal:  Br J Pharmacol       Date:  2015-12-19       Impact factor: 8.739

9.  Current neuroimaging techniques in Alzheimer's disease and applications in animal models.

Authors:  Linda Zhang; Raymond Chuen-Chung Chang; Leung-Wing Chu; Henry Ka-Fung Mak
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

10.  APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature.

Authors:  Peter T Nelson; Nina M Pious; Gregory A Jicha; Donna M Wilcock; David W Fardo; Steven Estus; G William Rebeck
Journal:  J Neuropathol Exp Neurol       Date:  2013-07       Impact factor: 3.148
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.